Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease

Scandinavian Cardiovascular Journal

Volumn 40, Issue 3, 2006, Pages 152-159

  Otterstad, Jan Erik ^a   Kirwan, Bridget Anne ^b   Lubsen, Jacobus ^b   de Brouwer, Sophie ^b   Fox, Keith A A ^c   Corell, Pernille ^d   Poole Wilson, Philip A ^e  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b SOCAR RESEARCH SA   (Switzerland)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; NIFEDIPINE; NITRATE; PLACEBO;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG FORMULATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NIFEDIPINE; PROGNOSIS;

EID: 33748342115     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430600746268     Document Type: Article

References (22)

1. Feinberg, WM and Blackshear, JL and Laupacis, A and Kronmal, R and Hart, RG. (1995) Prevalence, age, distribution, and gender of patients with atrial fibrillation: Analysis and implications Arch Intern Med., 155, pp. 469-73.
2. Benjamin, EJ and Wolf, PA and D'Agostino, RB and Silbershatz, H and Kannel, WB and Levy, D. (1998) Impact of atrial fibrillation on the risk of death: The Framingham Heart Study Circulation., 98, pp. 946-52.
3. Krahn, AD and Manfreda, J and Tate, RB and Mathewson, FA and Cuddy, TE. (1995) The natural history of atrial fibrillation; incidence, risk factors, and prognosis in the Manitoba follow-up study Am J Med., 98, pp. 476-84.
4. Crenshaw, BS and Ward, SR and Granger, CB and Stebbins, AL and Topol, EJ and Califf, RM. (1997) Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries J Am Coll Cardiol., 30, pp. 406-13.
5. Fuster, V and Ryden, LE and Asinger, RW and Cannom, DS and Crijns, HJ and Frye, RL and (2001) ACC/AHA/ESC guidelines for management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences Eur Heart J., 22, pp. 1852-1923.
6. Gajewski, J and Singer, RB. (1981) Mortality in an insured population with atrial fibrillation JAMA., 245, pp. 1540-4.
7. Kannel, WB and Abbot, RD and Savage, DD and McNamara, PM. (1982) Epidemiologic features of chronic atrial fibrillation; the Framingham Study N Engl J Med., 306, pp. 1018-22.
8. Lubsen, J and Poole-Wilson, PA and Pocock, SJ and van Dalen, FJ and Baumann, J and Kirwan, BA and (1998) Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS Eur Heart J, 19(Suppl I), pp. 20-32.
9. Otterstad, JE and Froeland, G and St. John Sutton, M and Holme, I. (1997) Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function Eur Heart J., 18, pp. 507-13.
10. Simon, R and Makuch, RW. (1984) A non-parametric graphical representation of the relationship between survival and the occurrence of an event: Application to responder versus non-responder bias Stat Med., 3, pp. 35-44.
11. The national heart, lung and blood institute working group on Atrial Fibrillation. (1993) Atrial fibrillation: Current understandings and research imperatives J Am Coll Cardiol., 22, pp. 1830-4.
12. Pedersen, OD and Bagger, H and Kober, L and Torp-Pedersen, C. (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation., 100, pp. 376-80.
13. Savelieva, I and Camm, AJ. (2001) Clinical trends in atrial fibrillation at the turn of the millennium J Intern Med., 250, pp. 369-72.
14. Tamakoshi, K and Yatsuya, H and Kondo, T and Hori, Y and Ishikawa, M and Zhang, H and (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state Int J Obes Relat Metab Disord., 27, pp. 443-9.
15. Rathore, SS and Berger, AK and Weinfurt, KP and Schulman, KA and Oetgen, WJ and Gersh, BJ and (2000) Acute myocardial infarction complicated by atrial fibrillation in the elderly: Prevalence and outcomes Circulation., 101, pp. 969-74.
16. Lehto, M and Snapinn, S and Dickstein, K and Swedberg, K and Nieminen, MS. (2005) Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: The OPTIMAAL experience Eur Heart J., 26, pp. 350-6.
17. Snow, V and Weiss, KB and LeFevre, M and McNamara, R and Bass, E and Green, LA and (2003) Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians Ann Intern Med., 139, pp. 1009-17.
18. O'Donnell, M and Agnelli, G and Weitz, JI. (2005) Emerging therapies for stroke prevention in atrial fibrillation Eur Heart J, 7(Suppl C), pp. C19-C27.
19. Rashid, P and Leonardi-Bee, J and Bath, P. (2003) Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review Stroke., 34, pp. 2741-8.
20. Gersh, BJ and Tsang, TSM and Barnes, ME and Seward, JB. (2005) The changing epidemiology of non-valvular atrial fibrillation: The role of novel risk factors Eur Heart J, 7(Suppl C), pp. C5-C11.
21. Poole-Wilson, PA and Lubsen, J and Kirwan, BA and van Dalen, F and Wagener, G and Danchin, N and (2004) Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomised controlled trial Lancet., 364, pp. 849-57.
22. Vermes, E and Tardif, JC and Bourassa, MG and Racine, N and Levesque, S and White, M and (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction. Insights from the Studies of Left Ventricular Dysfunction (SOLVD) Trials Circulation., 107, pp. 2926-31.